💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Seattle Genetics, Inc. (SGEN)
« Back to company indexSGEN Chatter Timeline
Stock Ticker for SGEN
Most Active Tweeters for SGEN
| User | Tweets |
|---|---|
| @FlashAlert_me | 13 |
| @SweepCastApp | 11 |
| @Tickeron | 9 |
| @MarcJacksonLA | 8 |
| @InsiderAlerts4U | 5 |
Recent Tweets for SGEN
 |
@SweepCastApp SweepCast ? Unusual Options Observed : $SGEN with our scanner on $150 CALL Expiring: 06/17/2022 worth 43K? Start Y… https://t.co/NYIXdlKSId May 28th 2022, 5:05pm |
 |
@Tickeron $SGEN in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 9, 2022. View odds for this a… https://t.co/OMaLbzHwK1 May 27th 2022, 6:05pm |
 |
@atimeywimey $SGEN 77.78% Profitability across 11 trades in 1 month. Profit Factor of 6.07 and rating is Bearish. Get started fo… https://t.co/UJNRkgyMs6 May 27th 2022, 1:05pm |
 |
@MaiteMerenda $SGEN 73.08% Win rate on 32 trades in 1 month. Profit Factor of 2.61, rating is Bullish. ? Stock Trading Ideas by… https://t.co/balcyPAJnI May 27th 2022, 11:05am |
 |
@Interna44849650 $SGEN Top analyst price target today..... ? https://t.co/RFy0DoX5HQ May 27th 2022, 12:05am |
 |
@InsiderAlerts4U $SGEN: New Insider Filing on Seagen Inc.'s Chief Technical Officer VAUGHN B HIMES: https://t.co/4QAuwKmnFk May 26th 2022, 11:05pm |
 |
@day_trading_de SGEN (Seagen Inc.) ? #Insider #stock alert! ? #Sale on 2022-05-24 - $SGEN ??: HIMES VAUGHN B (Chief Technical Offic… https://t.co/VN6UDcDwBT May 26th 2022, 10:05pm |
 |
@FlashAlert_me $SGEN [15s. delayed] filed SEC form 4: Chief Technical Officer HIMES VAUGHN B: Disposed 10,866 of Common Stock at… https://t.co/xMKGI9glTJ May 26th 2022, 10:05pm |
 |
@FintelAlerts Insider Vaughn B Himes reports selling 10,866 shares of $SGEN for a total cost of $1,486,376.51 https://t.co/9EZLYRMF4A May 26th 2022, 10:05pm |
 |
@MarcJacksonLA $TAK $SGEN Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement… https://t.co/XxyEFmxUKE May 26th 2022, 10:05pm |
|
@MarcJacksonLA $SGEN $TAK ASCO: Seagen, Takeda think Adcetris can become a force as a lymphoma combo drug https://t.co/Vh359gpvkH May 26th 2022, 10:05pm |
 |
@otcdynamics $SGEN Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement in Ov… https://t.co/K85wSNk316 May 26th 2022, 9:05pm |
 |
@StockNewsBot2 $TAK $SGEN Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement… https://t.co/snXysX7TLD May 26th 2022, 9:05pm |
 |
@FastestAlert $TAK $SGEN Takeda And Seagen To Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement… https://t.co/WQ4juaNoqG May 26th 2022, 9:05pm |
 |
@stock_titan $TAK $SGEN Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement… https://t.co/4Nw9ia0VHz May 26th 2022, 9:05pm |
|
@atimeywimey $SGEN 73.08% Profitability across 32 trades in 1 month. Profit Factor of 2.61 and rating is Bullish. Get started fo… https://t.co/wLnniIGvrl May 26th 2022, 2:05pm |
 |
@ShortAlgoTrades $SGEN Trading Ideas | Awaiting Buy signal. 85.71% Profitability based on 7 trades. Profit factor is 10.74. Learn mo… https://t.co/n3CxF5xbTo May 26th 2022, 10:05am |
 |
@stockresearchhq Seagen Inc's quarterly revenue growth rate YoY of 28.50% ranked 1325 out of 5721 companies in our database. https://t.co/azm50ywSNm $SGEN May 25th 2022, 11:05am |
|
@MarcJacksonLA $SGEN Tucatinib Plus Trastuzumab Yields Positive Topline Data in Phase 2 MOUNTAINEER Trial for HER2+ mCRC… https://t.co/jvAsT94jVb May 24th 2022, 10:05pm |
|
@MarcJacksonLA $SGEN JMP Securities Reiterates Seagen Buy Rating, $157 PT https://t.co/xKruSlBFiq May 24th 2022, 7:05pm |
|
@SweepCastApp SweepCast ? Unusual Options Observed : $SGEN with our scanner on $195 CALL Expiring: 09/16/2022 worth 163K? Start… https://t.co/LfM6vIhBJc May 24th 2022, 6:05pm |
 |
@BertrandBio @JacobPlieth I am not sure for $SGEN, but I think that $ALLO began dosing with their CAR-T with niro since data are… https://t.co/bg195ye1lP May 24th 2022, 1:05pm |
 |
@JacobPlieth Has this $SWTX $SGEN BCMA combo trial begun yet? https://t.co/9fAcOFqmSs May 24th 2022, 1:05pm |
|
@SweepCastApp SweepCast ? Unusual Options Observed : $SGEN with our scanner on $195 CALL Expiring: 09/16/2022 worth 163K? Start… https://t.co/Bt2O7nlc25 May 24th 2022, 12:05pm |
|
@stockresearchhq Seagen Inc's quarterly revenue growth rate YoY of 28.50% ranked 1326 out of 5724 companies in our database. https://t.co/azm50ywSNm $SGEN May 24th 2022, 12:05am |
|
@Tickeron $SGEN's price moved above its 50-day Moving Average on May 16, 2022. View odds for this and other indicators:… https://t.co/9XCcTQB8ir May 23rd 2022, 5:05pm |
 |
@Quantumup1 BofA $SGEN Buy$170: +VE MOUNTAINEER Data Supports Growth Thesis, featuring 38% ORR/12.4mos DoR. Promising data de-r… https://t.co/bilJux8C3F May 23rd 2022, 4:05pm |
 |
@newsfilterio Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer $SGEN https://t.co/fgLtp62yqe May 23rd 2022, 2:05pm |
|
@MarcJacksonLA $SGEN Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combina… https://t.co/qpT12Ggbx8 May 23rd 2022, 1:05pm |
 |
@john_bresnahan RT @BullBearBres: $SGEN ?? Seagen Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Co… May 23rd 2022, 12:05pm |
 |
@BullBearBres $SGEN ?? Seagen Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib)… https://t.co/2KcBXtw7Lj May 23rd 2022, 12:05pm |
 |
@investor_feed $SGEN 8-K Seagen (23 May, 8:11am) ? Other Events; Financial Statements and Exhibits https://t.co/upPv4Ptw8m #SGEN #8K #Seagen #News May 23rd 2022, 12:05pm |
|
@FlashAlert_me $SGEN [15s. delayed] filed form 8-K on May 23, 08:11:02 https://t.co/CwIMUcMaP6 May 23rd 2022, 12:05pm |
 |
@Market_Newswire $SGEN SEC Filing: 8-K Other Events - Seagen Inc. (0001060736) May 23 https://t.co/AsCKJb7oH3 May 23rd 2022, 12:05pm |
|
@FlashAlert_me $SGEN [15s. delayed]: Issued Press Release on May 23, 08:00:00: Seagen Announces Positive Topline Results of Pivota… https://t.co/MFJtTvNhTB May 23rd 2022, 12:05pm |
|
@StockNewsBot2 $SGEN Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combina… https://t.co/z5EISneT6j May 23rd 2022, 12:05pm |
 |
@hephaistos_ai RT @FastestAlert: $SGEN Seagen Announces Positive Topline Results Of Pivotal Phase 2 Clinical Trial Of TUKYSA® (tucatinib) In Combination W… May 23rd 2022, 12:05pm |
|
@FastestAlert $SGEN Seagen Announces Positive Topline Results Of Pivotal Phase 2 Clinical Trial Of TUKYSA® (tucatinib) In Combina… https://t.co/14GI4kdZGa May 23rd 2022, 12:05pm |
 |
@WebChronicleTo1 $SGEN Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combina… https://t.co/UvSy0exvay May 23rd 2022, 12:05pm |
|
@hephaistos_ai RT @stock_titan: $SGEN Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combination Wi… May 23rd 2022, 12:05pm |
|
@stock_titan $SGEN Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combina… https://t.co/MPNYa2wwUe May 23rd 2022, 12:05pm |
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in SEATTLE GENETICS $SGEN https://t.co/afZfV4OPyf May 22nd 2022, 6:05am |
|
@Tickeron $SGEN in Uptrend: price may jump up because it broke its lower Bollinger Band on May 9, 2022. View odds for this an… https://t.co/UGZ3WClfei May 20th 2022, 3:05pm |
|
@Tickeron $SGEN was the market's top quarterly gainer, rising +15.17% #Seagen https://t.co/cRZAvUOamw May 20th 2022, 2:05am |
|
@Tickeron $SGEN's price moved above its 50-day Moving Average on May 16, 2022. View odds for this and other indicators:… https://t.co/YBb84GXcBy May 20th 2022, 1:05am |
|
@FlashAlert_me $SGEN [15s. delayed] filed form 8-K on May 19, 16:47:55 https://t.co/5kmnNVOL0d May 19th 2022, 8:05pm |
|
@investor_feed $SGEN 8-K Seagen (19 May, 4:47pm) ? Submission of Matters to a Vote of Security Holders… https://t.co/HYEvJmU6dZ May 19th 2022, 8:05pm |
|
@SweepCastApp SweepCast ? Unusual Options Observed : $SGEN with our scanner on $140 CALL Expiring: 09/16/2022 worth 40K? Start Y… https://t.co/QZVPYL2l0b May 19th 2022, 1:05pm |
|
@SweepCastApp SweepCast ? Unusual Options Observed : $SGEN with our scanner on $145 PUT Expiring: 06/17/2022 worth 66K? Start Yo… https://t.co/YimUOKvAkG May 19th 2022, 3:05am |
|
@Tickeron $SGEN in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 9, 2022. View odds for this a… https://t.co/Demiv4zAci May 19th 2022, 2:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.